Response to Comment on Niewczas et al. Circulating Modified Metabolites and a Risk of ESRD in Patients With Type 1 Diabetes and Chronic Kidney Disease. Diabetes Care 2017;40:383–39...

por Niewczas, Monika A., Krolewski, Andrzej S.
Publicado 2017

Elevation of circulating TNF receptors 1 and 2 increases the risk of end-stage renal disease in American Indians with type 2 diabetes

por PAVKOV, MEDA E., NELSON, ROBERT G., KNOWLER, WILLIAM C., CHENG, YILING, KROLEWSKI, ANDRZEJ S., NIEWCZAS, MONIKA A.
Publicado 2014

Circulating Osteoprotegerin in Chronic Kidney Disease and All-Cause Mortality

por Kamińska, Joanna, Stopiński, Marek, Mucha, Krzysztof, Pac, Michał, Gołębiowski, Marek, Niewczas, Monika A, Pączek, Leszek, Foroncewicz, Bartosz
Publicado 2021

Early Progressive Renal Decline Precedes the Onset of Microalbuminuria and Its Progression to Macroalbuminuria

por Krolewski, Andrzej S., Niewczas, Monika A., Skupien, Jan, Gohda, Tomhito, Smiles, Adam, Eckfeldt, Jon H., Doria, Alessandro, Warram, James H.
Publicado 2014

Synergism Between Circulating Tumor Necrosis Factor Receptor 2 and HbA(1c) in Determining Renal Decline During 5–18 Years of Follow-up in Patients With Type 1 Diabetes and Proteinu...

por Skupien, Jan, Warram, James H., Niewczas, Monika A., Gohda, Tomohito, Malecki, Maciej, Mychaleckyj, Josyf C., Galecki, Andrzej T., Krolewski, Andrzej S.
Publicado 2014

Circulating short and medium chain fatty acids are associated with normoalbuminuria in type 1 diabetes of long duration

por Moon, Salina, Tsay, John J., Lampert, Heather, Md Dom, Zaipul I., Kostic, Aleksandar D., Smiles, Adam, Niewczas, Monika A.
Publicado 2021

Transcriptome Analysis of Proximal Tubular Cells (HK-2) Exposed to Urines of Type 1 Diabetes Patients at Risk of Early Progressive Renal Function Decline

por Wanic, Krzysztof, Krolewski, Bozena, Ju, Wenjun, Placha, Grzegorz, Niewczas, Monika A., Walker, William, Warram, James H., Kretzler, Matthias, Krolewski, Andrzej S.
Publicado 2013

The early decline in renal function in patients with type 1 diabetes and proteinuria predicts the risk of end stage renal disease

por Skupien, Jan, Warram, James H., Smiles, Adam M., Niewczas, Monika A., Gohda, Tomohito, Pezzolesi, Marcus G., Cantarovich, Diego, Stanton, Robert, Krolewski, Andrzej S.
Publicado 2012

Tumor necrosis factor receptors 1 and 2 are associated with early glomerular lesions in type 2 diabetes

por Pavkov, Meda E., Weil, E. Jennifer, Fufaa, Gudeta D., Nelson, Robert G., Lemley, Kevin V., Knowler, William C., Niewczas, Monika A., Krolewski, Andrzej S.
Publicado 2016

Increased plasma Kidney Injury Molecule-1 suggests early progressive renal decline in non-proteinuric patients with Type 1 diabetes

por Nowak, Natalia, Skupien, Jan, Niewczas, Monika A., Yamanouchi, Masayuki, Major, Melissa, Croall, Stephanie, Smiles, Adam, Warram, James H., Bonventre, Joseph V., Krolewski, Andrzej S.
Publicado 2016

Circulating Modified Metabolites and a Risk of ESRD in Patients With Type 1 Diabetes and Chronic Kidney Disease

por Niewczas, Monika A., Mathew, Anna V., Croall, Stephanie, Byun, Jaeman, Major, Melissa, Sabisetti, Venkatta S., Smiles, Adam, Bonventre, Joseph V., Pennathur, Subramaniam, Krolewski, Andrzej S.
Publicado 2017

Risk of ESRD and All Cause Mortality in Type 2 Diabetes According to Circulating Levels of FGF-23 and TNFR1

por Lee, Jung Eun, Gohda, Tomohito, Walker, William H., Skupien, Jan, Smiles, Adam M., Holak, Rita R., Jeong, Jackson, McDonnell, Kevin P., Krolewski, Andrzej S., Niewczas, Monika A.
Publicado 2013

High-Normal Serum Uric Acid Increases Risk of Early Progressive Renal Function Loss in Type 1 Diabetes: Results of a 6-year follow-up

por Ficociello, Linda H., Rosolowsky, Elizabeth T., Niewczas, Monika A., Maselli, Nicholas J., Weinberg, Janice M., Aschengrau, Ann, Eckfeldt, John H., Stanton, Robert C., Galecki, Andrzej T., Doria, Alessandro, Warram, James H., Krolewski, Andrzej S.
Publicado 2010

Interleukin-10(+) Regulatory B Cells Arise Within Antigen-Experienced CD40(+) B Cells to Maintain Tolerance to Islet Autoantigens

por Kleffel, Sonja, Vergani, Andrea, Tezza, Sara, Ben Nasr, Moufida, Niewczas, Monika A., Wong, Susan, Bassi, Roberto, D’Addio, Francesca, Schatton, Tobias, Abdi, Reza, Atkinson, Mark, Sayegh, Mohamed H., Wen, Li, Wasserfall, Clive H., O’Connor, Kevin C., Fiorina, Paolo
Publicado 2015

Uremic solutes and risk of end stage renal disease in type 2 diabetes

por Niewczas, Monika A, Sirich, Tammy L, Mathew, Anna V, Skupien, Jan, Mohney, Robert P, Warram, James H, Smiles, Adam, Huang, Xiaoping, Walker, Walker, Byun, Jaeman, Karoly, Edward D, Kensicki, Elizabeth M, Berry, Gerard T, Bonventre, Joseph V, Pennathur, Subramaniam, Meyer, Timothy W, Krolewski, Andrzej S
Publicado 2014

Metabolomic Profiling in Individuals with a Failing Kidney Allograft

por Bassi, Roberto, Niewczas, Monika A., Biancone, Luigi, Bussolino, Stefania, Merugumala, Sai, Tezza, Sara, D’Addio, Francesca, Ben Nasr, Moufida, Valderrama-Vasquez, Alessandro, Usuelli, Vera, De Zan, Valentina, El Essawy, Basset, Venturini, Massimo, Secchi, Antonio, De Cobelli, Francesco, Lin, Alexander, Chandraker, Anil, Fiorina, Paolo
Publicado 2017

A Signature of Circulating Inflammatory Proteins and Development of End Stage Renal Disease in Diabetes

por Niewczas, Monika A., Pavkov, Meda E., Skupien, Jan, Smiles, Adam, Dom, Zaipul I. Md., Wilson, Jonathan M., Park, Jihwan, Nair, Viji, Schlafly, Andrew, Saulnier, Pierre-Jean, Satake, Eiichiro, Simeone, Christopher A., Shah, Hetal, Qiu, Chengxiang, Looker, Helen C, Fiorina, Paolo, Ware, Carl F., Sun, Jennifer K., Doria, Alessandro, Kretzler, Matthias, Susztak, Katalin, Duffin, Kevin L., Nelson, Robert G., Krolewski, Andrzej S.
Publicado 2019